Multicentric Latin American study of 211 patients with Interstitial lung disease and myositis related antibodies
F. Reyes (Santiago, Chile), V. Wolff (Santiago, Chile), L. Alberti (Buenos Aires, Argentina), E. Juarez (Mexico DF, Mexico), V. Leiva (Santiago, Chile), L. Fassola (Buenos Aires, Argentina), M. Mejia (Mexico DF, Mexico), I. Buendia (Mexico DF, Mexico), F. Caro (Buenos Aires, Argentina), J. Rojas Serrano (Mexico DF, Mexico), F. Paulin (Buenos Aires, Argentina), M. Florenzano (Santiago, Chile)
Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Reyes (Santiago, Chile), V. Wolff (Santiago, Chile), L. Alberti (Buenos Aires, Argentina), E. Juarez (Mexico DF, Mexico), V. Leiva (Santiago, Chile), L. Fassola (Buenos Aires, Argentina), M. Mejia (Mexico DF, Mexico), I. Buendia (Mexico DF, Mexico), F. Caro (Buenos Aires, Argentina), J. Rojas Serrano (Mexico DF, Mexico), F. Paulin (Buenos Aires, Argentina), M. Florenzano (Santiago, Chile). Multicentric Latin American study of 211 patients with Interstitial lung disease and myositis related antibodies. 4744
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: